Pre-existing levels of CD4 T cells expressing PD-1 are related to overall survival in prostate cancer patients treated with ipilimumab
Kwek, S. S., Lewis, J., Zhang, L., Weinberg, V., Greaney, S., Harzstark, A., Lin, A., Ryan, C., Small, E. J., Fong, L.Language:
english
Journal:
Cancer Immunology Research
DOI:
10.1158/2326-6066.CIR-14-0227
Date:
May, 2015
File:
PDF, 1.25 MB
english, 2015